Article

Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin (IREC) for refractory or relapsed neuroblastoma

2020-12-28

Abstract excerpt

<h4>Background: </h4> Patients with relapsed or refractory neuroblastoma have a poor prognosis; there are limited effective and safe rescue chemotherapies for these patients. Development of new chemotherapy regimens for these patients is a key imperative. Procedure: We retrospectively analyzed patients with refractory or relapsed neuroblastoma who received irinotecan, etoposide, and carboplatin (IREC) as a second-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 251cab27-e33c-5068-b2d4-9a14872935da
DOI: 10.22541/au.160911726.62502335/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin (IREC) for refractory or relapsed neuroblastomaDOI 10.22541/au.160911726.62502335/v1Read

Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.Semantic proximity Read

Investigational drugs in phase II clinical trials for the treatment of neuroblastomaSemantic proximity Read

Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview.Semantic proximity Read

Mechanism of drug resistance to first-line chemotherapeutics mediated by TXNDC17 in neuroblastomasSemantic proximity Read

Personalized prophylactic antiemetic regimens for the control of chemotherapy-induced nausea and vomiting by pharmacogenetic analysis of three receptors genes:<i>HTR3A, HTR3B, TACR1</i>Semantic proximity Read

Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study.Semantic proximity Read

Survival in patients with high-risk neuroblastoma treated without autologous stem cell transplant or dinutuximab betaSemantic proximity Read

[Correlation between nUGT1A1 gene polymorphisms and adverse events of irinotecan plus S-1 for patients with recurrent or metastatic esophageal squamous cell carcinoma: a prospective, open-label, randomized controlled trial (ESWN 01)].Semantic proximity Read

Association of UGT1A1*6,*28 or ABCC2 c.3972C>T genetic polymorphisms with irinotecan induced toxicity in Asian cancer patients: Meta-analysisSemantic proximity Read

Association between a single nucleotide polymorphism in the R3HCC1 gene and irinotecan toxicity.Semantic proximity Read

Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer.Semantic proximity Read

Determination of the UGT1A1 polymorphism as guidance for irinotecan dose adjustment in gastric cancer treated with second-line chemotherapySemantic proximity Read